Celyad SA

Company Profile

Celyad SA had its IPO on 2015-06-19 under the ticker symbol CYAD.

The company operates in the Healthcare sector and Biotechnology industry. Celyad SA has a staff strength of 95 employees.

Stock update

Shares of Celyad SA opened at $0.83 at the start of the last trading session i.e. 2023-03-24.

The stocks traded within a range of $0.83 - $0.96, and closed at $0.88.

This is a +1.23% increase from the previous day's closing price.

A total volume of 4,147 shares were traded at the close of the day’s session.

In the last one week, shares of Celyad SA have slipped by -6.3%.

Celyad SA's Key Ratios

Celyad SA has a market cap of $21.14 million, indicating a price to book ratio of 0.6921 and a price to sales ratio of 12738.134.

In the last 12-months Celyad SA’s revenue was $0 with a gross profit of $5000 and an EBITDA of $-28706000. The EBITDA ratio measures Celyad SA's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Celyad SA’s operating margin was 0% while its return on assets stood at -29.33% with a return of equity of -92.64%.

In Q2, Celyad SA’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.

Celyad SA’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-1.4 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Celyad SA’s profitability.

Celyad SA stock is trading at a EV to sales ratio of 11209.6676 and a EV to EBITDA ratio of -0.4501. Its price to sales ratio in the trailing 12-months stood at 12738.134.

Celyad SA stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$63.14 million

Total Liabilities

$11.36 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Celyad SA ended 2023 with $63.14 million in total assets and $0 in total liabilities. Its intangible assets were valued at $63.14 million while shareholder equity stood at $30.65 million.

Celyad SA ended 2023 with $441000.00 in deferred long-term liabilities, $11.36 million in other current liabilities, 78585000.00 in common stock, $-323053000.00 in retained earnings and $883000.00 in goodwill. Its cash balance stood at $14.39 million and cash and short-term investments were $14.39 million. The company’s total short-term debt was $783,000 while long-term debt stood at $0.

Celyad SA’s total current assets stands at $19.38 million while long-term investments were $0 and short-term investments were $0.00. Its net receivables were $3.72 million compared to accounts payable of $6.01 million and inventory worth $0.

In 2023, Celyad SA's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Celyad SA paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$0.88

52-Week High

$3.07

52-Week Low

$0.46

Analyst Target Price

$8.52

Celyad SA stock is currently trading at $0.88 per share. It touched a 52-week high of $3.07 and a 52-week low of $3.07. Analysts tracking the stock have a 12-month average target price of $8.52.

Its 50-day moving average was $1.23 and 200-day moving average was $1.38 The short ratio stood at 0.23 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 2915.5% are held by institutions.